Home » Topics » Regulatory

Regulatory
RSS

FDA approves new indications for Zerit and Videx

Sep. 9, 1999

New ulcer drug approved for the first time in Japan

Sep. 1, 1999

Eisai's proton pump inhibitor approved in E.U. for GERD maintenance

Sep. 1, 1999

Celecoxib NDA receives priority review designation for FAP

Aug. 31, 1999

NDA for subcutaneous Repronex approved by FDA

Aug. 31, 1999

Temodal approved in E.U. for treatment of recurrent anaplastic astrocytoma

Aug. 27, 1999

InterMune files BLA for Actimmune for treatment of osteopetrosis

Aug. 25, 1999

Bio-Technology General granted additional patent allowance for oxandrolone

Aug. 24, 1999

QLT begins phase II trial for psoriasis treatment

Aug. 24, 1999

Chiron initiates phase III study of Proleukin for HIV

Aug. 23, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...